Amkay Products Ltd vs Galaxy Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Amkay Products Ltd is ₹ 53.5 as of 23 Oct 15:30 . The P/E Ratio of Amkay Products Ltd changed from 10.3 on March 2025 to 19.5 on March 2026 . This represents a CAGR of 37.59% over 2 yearsThe P/E Ratio of Galaxy Medicare Ltd changed from 7.3 on March 2026 to 7.3 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Amkay Products Ltd changed from ₹ 34.41 crore on March 2025 to ₹ 45.01 crore on March 2026 . This represents a CAGR of 14.37% over 2 yearsThe Market Cap of Galaxy Medicare Ltd changed from ₹ 25.03 crore on March 2026 to ₹ 25.03 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The Dividend Payout of Amkay Products Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Galaxy Medicare Ltd changed from 9.72 % on March 2021 to 31.05 % on March 2026 . This represents a CAGR of 21.36% over 6 years .

About Amkay Products Ltd

Amkay Products Limited was originally incorporated as 'Amkay Products Private Limited' on October 25, 2007 with the Registrar of Companies, Mumbai.
Subsequently, the Company was converted into a Public Limited Company and the name was changed from 'Amkay Products Private Limited' to 'Amkay Products Limited' vide a fresh Certificate of Incorporation dated August 28, 2023, issued by the Registrar of Companies, Maharashtra, Mumbai. The Company manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Steel/ Plastic Lancet Needles, Air Bed, Apron, Digital Thermometer, Nebulizer, Shoe Cover, BP Monitor, Pulse Oximeter, Surgeon Cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. widely spread across India.

About Galaxy Medicare Ltd

Galaxy Medicare Limited was originally established on July 23, 1992 as a Limited Company in the Mancheshwar Industrial area of Bhubaneswar, Orissa.
The Company commenced its operations in 1992 when the founder, Mr. Dillip Kumar Das, acquired a closed business unit, M/s Cure Aids Private Limited from Odisha Industrial Infrastructure Development Corporation (IDCO) and Odisha State Financial Corporation under the investment promotion, facilitation and aftercare strategy of Industrial Promotion and Investment Corporation of Odisha (IPICOL) and revived the business unit to start manufacturing of Medical Devices such as Plaster of Paris Bandage (POP Bandage), Medical Tapes and Bandages, Other surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, etc.

FAQs for the comparison of Amkay Products Ltd and Galaxy Medicare Ltd

Which company has a larger market capitalization, Amkay Products Ltd or Galaxy Medicare Ltd?

Market cap of Amkay Products Ltd is 46 Cr while Market cap of Galaxy Medicare Ltd is 27 Cr

What are the key factors driving the stock performance of Amkay Products Ltd and Galaxy Medicare Ltd?

The stock performance of Amkay Products Ltd and Galaxy Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amkay Products Ltd and Galaxy Medicare Ltd?

As of October 24, 2026, the Amkay Products Ltd stock price is INR ₹53.5. On the other hand, Galaxy Medicare Ltd stock price is INR ₹18.05.

How do dividend payouts of Amkay Products Ltd and Galaxy Medicare Ltd compare?

To compare the dividend payouts of Amkay Products Ltd and Galaxy Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.